1 Arndt P A,Garratty G. The changing spectrum of drug-induced immune hemolytic anemia[J]. Semin Hematol,2005,42(3):137-144. 2 Garratty G,Arndt P A. An update on drug-induced immune hemolytic anemia[J]. Immunohematol,2007,23(3):105-119. 3 Leger R M,Co A,Hunt P,et al. Attempts to support an immune etiology in 800 patients with direct antiglobulin test-negative hemolytic anemia[J]. Immunohematol,2010,26(4):156-160. 4 Judd J,Johnson S. Judd's Methods in immunohematol[M]. 3rd edition. AABB Press Bethesda,2008. 5 Garratty G. Immune hemolytic anemia associated with drug therapy[J]. Blood Rev,2010,24(4-5):143-150. 6 O'Neil M J. The Merck index:An encyclopedia of chemicals,drugs,and biologicals[M]. 14th ed. Whitehouse Station,NJ:Merck,2006 (or current edition). 7 Petz L D,Garratty G. Acquired hemolytic anemias[M]. 2nd ed. Philadelphia,PA:Churchill-Livingstone,2004. 8 Physicians' desk reference. Montvale,NJ:Thomson Healthcare,2008 (updated annually). 9 Davenport R D,Judd WJ,Dake L R. Persistence of cefotetan on red blood cells[J]. Transfusion,2004,44(6):849-852. 10 Arndt P A.,Leger R M,Garratty G. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia[J]. Transfusion,2012,52(3):602-612. 11 Judd W J. Investigation and management of immune hemolysis: Autoantibodies and drugs[A]. In:Wallace ME,Levitt JS,eds. Current applications and interpretation of the direct antiglobulin test[M]. Arlington,VA:AABB,1988:47-103. 12 Garratty G. Laboratory investigation of drug-induced immune hemolytic anemia[M]. In:Bell CA,ed. A seminar on laboratory management of hemolysis(supplement). Washington,DC:AABB,1979. 13 Pierce A,Nester T. Pathology consultation on drug-induced hemolytic anemia[J]. Am J Clin Pathol,2011,136(1):7-12. 14 Roback J,Combs M R,Grossman B,Hillyer C. Technical manual[M]. 16th ed. Bethesda,MD:AABB,2008. 15 Bougie D,Johnson S T,Weitekamp L A,et al. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia[J]. Blood,1997,90:407-413 16 Cuhha P D,Lord R S,Johnson S T,et al. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac,a nonsteroidal anti-inflammatory drug[J]. Transfusion,2000,40:663-668. |